Reinfection, recontamination and revaccination for SARS-CoV-2

Area of Science:

• Virology
• Epidemiology
• Immunology

Background:

• The COVID-19 pandemic has been characterized by recurring waves of infections and deaths.
• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutates, leading to repeated outbreaks in both naturally immune and vaccinated populations.
• While vaccination reduced complications, it has not fully attenuated disease expansion.

Purpose of the Study:

• To review recent data on SARS-CoV-2 reinfection rates in vaccinated and unvaccinated individuals.
• To differentiate between reinfection and recontamination with SARS-CoV-2.
• To inform future vaccine distribution strategies based on prior infection immunity.

Main Methods:

• Review of recent data on SARS-CoV-2 reinfection.
• Analysis of criteria to distinguish reinfection from recontamination.
• Evaluation of the impact of vaccination on disease spread.

Main Results:

• Positive SARS-CoV-2 tests after initial infection may indicate recontamination, not necessarily reinfection.
• Symptom-free outcomes and rapid PCR test reconversion can suggest recontamination.
• The protective effect of prior infection may be underestimated in current vaccine strategies.

Conclusions:

• Distinguishing between SARS-CoV-2 reinfection and recontamination is crucial for accurate epidemiological assessment.
• This distinction can aid in managing human resources during outbreaks.
• Prior infection's protective value should be considered for optimizing future vaccine distribution.